Biotech grants in the United States
Explore Biotech grants for companies in the United States. This list brings together funding for drug discovery, diagnostics, cell and gene therapy, biomanufacturing and life-science research from US innovation agencies, research funders and foundations, international programs open to applicants in the United States, and competitions any company can enter, with the deadline, award size and eligibility on every listing. Grants aimed at Biotech in the United States come first.
Showing 97-120 of 1,239 grants
MRA Pilot Award
๐บ๐ธMRA ยท United States
Funds high-risk melanoma proof-of-concept efforts through grants for high-impact experimental ideas.
MRA Young Investigator Award
๐บ๐ธMRA ยท United States
Supports early-career melanoma researchers through fellowships and grants that launch independent research direction.
Strategic Research Agreement โ Round 1
๐บ๐ธBreakthrough T1D ยท United States
Funds investigator-led type 1 diabetes research partnerships across preclinical discovery, treatment, and translational priorities.
Cancer Research KI-Mayo Clinic CCC Synergy Grants
๐บ๐ธMCCCC & CRKI ยท Global / Multinational
Funds Mayo Clinic and Karolinska Institutet teams researching early cancer detection.
DoW Parkinson's, Early Investigator Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds early-career Parkinson's research, with a required mentor at the fellow level and none needed at the independent level.
DoW Parkinson's, Investigator-Initiated Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds rigorous Parkinson's disease research for investigators at any career stage, with an optional second PI and clinical trials allowed.
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access
๐บ๐ธNIH ยท United States
Funds research using data from expanded access to investigational drugs for people with ALS who are not eligible for any ongoing trial.
NIH Research Evaluation and Commercialization Hubs (REACH)
๐บ๐ธNIH ยท United States
Funds five university-based hubs that turn NIH-backed biomedical discoveries into products.
DoW Spinal Cord Injury, Clinical Translation Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds pilot and feasibility work that prepares a spinal cord injury approach for a future, larger clinical trial.
DoW Spinal Cord Injury, Clinical Trial Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds a spinal cord injury clinical trial that opens with a pre-application stage and calls for named community partners throughout.
DoW Spinal Cord Injury, Investigator-Initiated Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds spinal cord injury research from basic science through translation, open to investigators at any career stage.
DoW Spinal Cord Injury, Translational Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds translational spinal cord injury research toward clinical use, with a named community partner and about $2.08 million per award on average.
DoW Vision, Clinical Trial Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds a clinical trial for service-connected eye injury or visual dysfunction, with a regulatory clock that runs past the application deadline itself.
DoW Vision, Investigator-Initiated Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds basic-through-early-translational research on service-connected eye injury or visual dysfunction โ clinical trials are not part of this one.
DoW Vision, Translational Research Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds translational work turning a vision-research discovery into a drug, device or guideline ready for a definitive clinical trial.
Childhood, Adolescent and Young Adult (AYA) Cancer Data Innovation Challenge โ Track 1
๐บ๐ธNCI ยท United States
Pays entities up to $566,665 across three milestones to add shovel-ready cancer data or tools to NCI's CCDI ecosystem.
Draper TIF
๐บ๐ธUW Entrepreneurship Hub + WiSys ยท United States
Funds WARF-disclosed UW Madison inventions through patent and licensing preparation for market-ready transfer.
NCCIH Natural Product Early Phase Clinical Trial Award
๐บ๐ธNIH ยท United States
Funds three years replicating a natural product's effect on its target in people, for teams that have already done the pharmacokinetics work.
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award
๐บ๐ธNIH ยท United States
Funds three years of pharmacokinetics and target-engagement work on a botanical, probiotic or supplement, then three more if the milestones are met.
NCCIH Natural Product Mid Phase Clinical Trial
๐บ๐ธNIH ยท United States
Funds the mid-phase study that settles a natural product's dose, formulation or responder group before anyone commits to a multi-site efficacy trial.
CRI Technology Impact Award
๐บ๐ธCRI ยท United States
Pays tenure-track researchers up to $600,000 to build unproven cancer immunotherapy technology.
DoW Joint Warfighter Medical, Military Medical Research and Development Award
๐บ๐ธMRDC / CDMRP ยท United States
Funds a continuation phase for medical research that already holds earlier DOD or DOW funding, from preclinical work through clinical trials.
Prevention and Intervention Approaches for FASD (R61/R33)
๐บ๐ธNIAAA ยท United States
Supports translational research for FASD prevention and intervention, moving through feasibility and expansion milestones.
TTP (TTP-T / TTP-P)
๐บ๐ธNSF TIP ยท United States
Funds NSF-funded research teams translating discoveries toward field use through industry-aligned pathways and partnerships.